4th Boehringer Ingelheim Expert Forum on Farm-Animal Well-Being
Boehringer Ingelheim has laid the foundation stone for its European Veterinary Research Center in Hanover.
Boehringer Ingelheim’s market leading Animal Health medication Metacam® (active ingredient: Meloxicam) obtained EU wide marketing authorisation as an oral suspension in a concentration of 15 mg/ml for use in pigs.
Boehringer Ingelheim’s Metacam® (active ingredient: Meloxicam) 5mg/ml solution for injection obtained EU wide marketing authorization for its use as an analgesic to relieve post operative pain associated with castration in piglets.
We need accurate ways to assess pain in pigs in order to evaluate the welfare consequences of interventions and to develop more effective pain mitigation strategies, according to a recently published review* of various methods currently under investigation.
Read and download the posters.
Get the latest news on Swine Health Subscribe to our newsletter